Hematologic Malignancies: Acute Leukemias
Buch in deiner Nähe kaufen
Beschreibung
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several chapters in this volume describe current knowledge of acute leukemia biology and discuss new classification systems that have arisen consequent to emerging insights into pathogenesis. Treatment has also improved for particular types of acute leukemia. Given our intention that the book be useful to clinicians, we pay particular attention to these advances, to management of acute leukemia in general, and to development of new therapies.
Massive practical value as clinicians are brought up to date on most recent advances in acute leukemia treatment
Authors delineate the development of new therapies
Lays out the current state of knowledge on the subject
Examines new classification systems that have been coming on stream
As research into cancers progresses, scientists are becoming ever more aware that better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis. Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia. Their book also covers the management of acute leukemia in general as well as the development of new therapies. This book will be extremely useful to clinicians.
Autor*in
Elihu H. Estey
Themen in »Hematologic Malignancies: Acute Leukemias«
Molecular Pathogenesis Prognoses Standard and New Therapies cell classification clinical trial genetics leukemia lymphoma molecular biology pathogenesis stem cell stem cell transplantation transplantation